David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Emerson Electric
EMR
|
+$546M |
| 2 |
Amazon
AMZN
|
+$515M |
| 3 |
Tesla
TSLA
|
+$389M |
| 4 |
Netflix
NFLX
|
+$322M |
| 5 |
Adobe
ADBE
|
+$305M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$836M |
| 2 |
CELG
Celgene Corp
CELG
|
+$460M |
| 3 |
NVIDIA
NVDA
|
+$429M |
| 4 |
ConocoPhillips
COP
|
+$311M |
| 5 |
Biogen
BIIB
|
+$301M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.8% |
| 2 | Consumer Discretionary | 11.76% |
| 3 | Healthcare | 10.16% |
| 4 | Financials | 7.89% |
| 5 | Industrials | 6.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2426
PUT
Sinclair Inc
SBGI
$1.04B
| $2.01M | ﹤0.01% |
+60,200
| New | +$2.24M |
|
2427
CALL
Medifast
MED
$137M
| $2M | ﹤0.01% |
18,300
+10,000
| +120% | +$968K |
|
2428
PUT
Raymond James Financial
RJF
$34B
| $2M | ﹤0.01% |
+33,600
| New | +$1.94M |
|
2429
Chemed
CHE
$7.17B
| $2M | ﹤0.01% |
4,553
-1,462
| -24% | -$615K |
|
2430
PUT
Helmerich & Payne
HP
$4.14B
| $2M | ﹤0.01% |
44,000
-98,700
| -69% | -$3.96M |
|
2431
CRA International
CRAI
$1.07B
| $2M | ﹤0.01% |
36,653
+17,141
| +88% | +$833K |
|
2432
PUT
Sturm, Ruger & Co
RGR
$611M
| $1.99M | ﹤0.01% |
42,400
-3,400
| -7% | -$154K |
|
2433
CALL
Crocs
CROX
$5.93B
| $1.99M | ﹤0.01% |
+47,500
| New | +$1.66M |
|
2434
Carriage Services
CSV
$552M
| $1.99M | ﹤0.01% |
77,556
+22,172
| +40% | +$538K |
|
2435
PUT
Nutanix
NTNX
$17.7B
| $1.99M | ﹤0.01% |
63,500
| – | – |
|
2436
CALL
Zoetis
ZTS
$32B
| $1.99M | ﹤0.01% |
15,000
| – | – |
|
2437
New Mountain Finance
NMFC
$715M
| $1.98M | ﹤0.01% |
144,194
+53,010
| +58% | +$718K |
|
|
SAVE
2438
CALL
DELISTED
Spirit Airlines, Inc.
SAVE
| $1.98M | ﹤0.01% |
49,100
+10,000
| +26% | +$380K |
|
2439
CALL
Parker-Hannifin
PH
$131B
| $1.98M | ﹤0.01% |
9,600
| – | – |
|
2440
PUT
Ovintiv
OVV
$17.8B
| $1.97M | ﹤0.01% |
84,000
-24,000
| -22% | -$514K |
|
|
TIF
2441
DELISTED
Tiffany & Co.
TIF
| $1.97M | ﹤0.01% |
14,735
+11,465
| +351% | +$1.36M |
|
|
JOYY
2442
JOYY Inc
JOYY
$3.66B
| $1.97M | ﹤0.01% |
37,239
+6,791
| +22% | +$400K |
|
|
ZVO
2443
DELISTED
Zovio Inc. Common Stock
ZVO
| $1.97M | ﹤0.01% |
954,523
-228,826
| -19% | -$457K |
|
2444
CALL
Devon Energy
DVN
$51.5B
| $1.96M | ﹤0.01% |
75,600
+7,800
| +12% | +$176K |
|
2445
CALL
PBF Energy
PBF
$8.27B
| $1.96M | ﹤0.01% |
62,500
| – | – |
|
2446
Hope Bancorp
HOPE
$1.78B
| $1.96M | ﹤0.01% |
131,688
+47,427
| +56% | +$688K |
|
|
SJR
2447
DELISTED
Shaw Communications Inc.
SJR
| $1.95M | ﹤0.01% |
96,292
-131,035
| -58% | -$2.64M |
|
2448
Phibro Animal Health
PAHC
$1.46B
| $1.95M | ﹤0.01% |
78,628
+50,339
| +178% | +$1.17M |
|
|
SRNE
2449
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $1.95M | ﹤0.01% |
576,145
+503,174
| +690% | +$1.2M |
|
2450
PLDT
PHI
$4.19B
| $1.94M | ﹤0.01% |
97,113
+68,753
| +242% | +$1.44M |
|
Similar funds
David Shaw's Q4 2019 Portfolio in Review
As of Q4 2019, David Shaw held 4,337 positions worth $87.5B, up 7.7% from $81.2B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
David Shaw withdrew a net $3.91B in Q4 2019, closing 412 positions and reducing 1,498 holdings. Its most notable exit was Celgene Corp, an estimated $460M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, David Shaw opened a new position in Tesla worth $501M.
- David Shaw's largest Q4 2019 buy was Tesla: 17,953,230 shares worth $501M.
- David Shaw added most to Emerson Electric in Q4 2019, an estimated $546M increase.
- David Shaw's biggest Q4 2019 reduction was Alibaba, cutting an estimated $836M.
- David Shaw fully exited Celgene Corp in Q4 2019, selling an estimated $460M.
- David Shaw's ten largest holdings make up 10% of its $87.5B portfolio in Q4 2019.
- David Shaw opened 572 new positions and closed 412 in Q4 2019.
- David Shaw's portfolio value rose 7.7% quarter-over-quarter to $87.5B.
Based on D.E. Shaw & Co's 13F filing for Q4 2019, filed 14 Feb 2020.